Medtronic PLC MDT
88.64
0.13
0.15%
as of 25 Sep
- Market cap
- $112.2B
- P/E
- 21.7×
Follow MDT
Indexes
indicate stock being part of an index,
Growth Flags
show if company had growth for consecutive years
Medtronic PLC (MDT) P/E ratio
As of 25 September 2026, Medtronic PLC (MDT) trades at a P/E ratio of 21.7×. Over the past ten years it has ranged from 18.4× (March 2020) to 61.4× (April 2021); the current reading is higher than 3% of that period. That is in line with the Medical Devices industry median of 22.2× and in line with the Healthcare sector median of 22.7×.
P/E ratio, daily
Annual
| Period | P/E ratio | Change |
|---|---|---|
| FY2026 | 21.6× | (7.28%) |
| FY2025 | 23.3× | (19.97%) |
| FY2024 | 29.2× | (8.94%) |
| FY2023 | 32.0× | 16.50% |
| FY2022 | 27.5× | (43.91%) |
| FY2021 | 49.0× | 79.30% |
| FY2020 | 27.3× | 5.93% |
| FY2019 | 25.8× | (26.22%) |
| FY2018 | 35.0× | 22.43% |
| FY2017 | 28.6× | (9.23%) |
Quarterly
| Period | P/E ratio | Change |
|---|---|---|
| Jul 2026 | 20.9× | (3.33%) |
| Apr 2026 | 21.6× | (24.33%) |
| Jan 2026 | 28.6× | 17.03% |
| Oct 2025 | 24.4× | (1.66%) |
| 43 more quarters | Free account |
Against its own ten years
Low 18.4×
High 61.4×
Ten-year median
28.4×
Current reading's percentile
3
P/E ratio against peers
| Company | P/E ratio |
|---|---|
| GEHC GE HealthCare Technologies Inc. compare | 15.3× |
| BSX Boston Scientific Corporation compare | 17.7× |
| PHG Koninklijke Philips N.V. compare | 18.2× |
| MDT Medtronic PLC | 21.7× |
| STE STERIS plc compare | 25.4× |
| SYK Stryker Corporation compare | 28.0× |
| ABT Abbott Laboratories compare | 32.8× |
| DXCM DexCom, Inc. compare | 33.4× |
| EW Edwards Lifesciences Corporation compare | 49.6× |
| Medical Devices industry median | 22.2× |
| Healthcare sector median | 22.7× |
| Market median | 17.9× |
What P/E ratio is
Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.
Stock Price ÷ EPS (Basic) (TTM)
More on MDT
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- The full statement